Literature DB >> 17953797

Population health impact of cancer in Canada, 2001.

Jane Boswell-Purdy1, William M Flanagan, Hélène Roberge, Christel Le Petit, Kathleen J White, Jean-Marie Berthelot.   

Abstract

Summary measures of population health that incorporate morbidity provide a new perspective for health policy and priority setting. Health-adjusted life years (HALYs) lost to a disease combine the impact of years of life lost to premature mortality and morbidity, measured as year-equivalents lost to reduced functioning. HALYs for 25 cancers were estimated from mortality and incidence in 2001 in Canada; population-attributable fractions were estimated for major risk factors contributing to these cancers. Results from this analysis indicate that Canadians would lose an estimated 905,000 health-adjusted years of life to cancer for 2001, including 771,000 to premature mortality and 134,000 to morbidity from incident cases (years discounted at 3 percent). Most of the estimated premature mortality was due to lung cancer; morbidity was largely due to breast, prostate and colorectal cancers. An estimated one quarter of HALYs lost to cancer were attributable to smoking and almost one quarter were attributable to alcohol consumption, lack of fruit and vegetables, obesity and physical inactivity combined. These results are a significant advance in measuring the population health impact of cancer in Canada because they incorporate morbidity as well as mortality.

Entities:  

Mesh:

Year:  2007        PMID: 17953797

Source DB:  PubMed          Journal:  Chronic Dis Can        ISSN: 0228-8699


  5 in total

1.  Estimation of cancer incidence and mortality attributable to overweight, obesity, and physical inactivity in China.

Authors:  Ding Wang; Wei Zheng; Shao-Ming Wang; Jian-Bing Wang; Wen-Qiang Wei; Hao Liang; You-Lin Qiao; Paolo Boffetta
Journal:  Nutr Cancer       Date:  2011-12-02       Impact factor: 2.900

Review 2.  Estimating population attributable fractions to quantify the health burden of obesity.

Authors:  Katherine M Flegal; Orestis A Panagiotou; Barry I Graubard
Journal:  Ann Epidemiol       Date:  2014-11-13       Impact factor: 3.797

3.  Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and duration.

Authors:  W K Evans; W M Flanagan; A B Miller; J R Goffin; S Memon; N Fitzgerald; M C Wolfson
Journal:  Curr Oncol       Date:  2016-06-09       Impact factor: 3.677

4.  Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model.

Authors:  William K Evans; Cindy L Gauvreau; William M Flanagan; Saima Memon; Jean Hai Ein Yong; John R Goffin; Natalie R Fitzgerald; Michael Wolfson; Anthony B Miller
Journal:  CMAJ Open       Date:  2020-09-22

5.  The OncoSim-Breast Cancer Microsimulation Model.

Authors:  Jean H E Yong; Claude Nadeau; William M Flanagan; Andrew J Coldman; Keiko Asakawa; Rochelle Garner; Natalie Fitzgerald; Martin J Yaffe; Anthony B Miller
Journal:  Curr Oncol       Date:  2022-03-03       Impact factor: 3.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.